查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529691

血气和电解质分析仪市场规模、份额、趋势分析报告：按产品、最终用途、按地区、细分市场预测，2024-2030 年

Blood Gas And Electrolyte Analyzer Market Size, Share & Trends Analysis Report By Products (Instruments, Consumables), By End-use (Clinical Laboratory, Point-of-care), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

血液气体和电解质分析仪市场成长和趋势：

Grand View Research Inc.的一项新研究显示，到2030年，全球血气和电解质分析仪市场规模预计将达到37.1亿美元，复合年增长率为4.5%。

ICU 和重症监护室患者数量的增加、对高通量和整合系统的需求不断增加是可能推动血液气体和电解质分析仪市场的主要因素。此外，全球老年人口的增加预计也将透过增加目标疾病的盛行率和扩大需要严重治疗的患者基础，对预测期内的市场成长做出重大贡献。此外，由于测试选单的扩展和对可携式设备的需求增加，预计多参数监测设备的出现将在预测期内推动利用率。血液气体分析仪的出现有助于加强对重症患者的护理，透过频繁诊断和监测呼吸系统疾病来指南预后和治疗。对具有先进技术、可在短时间内进行测量的手持设备的需求不断增长，导致更紧凑、更复杂的手持式照护现场设备的开发。例如，OPTI CCA-TS2 血气和电解质分析仪采用创新的光学技术，只需最少的维护即可快速提供结果。

血气和电解质分析仪市场报告亮点

  • 2023 年，消耗品将以 66.28% 的收益占有率主导市场，预计在预测期内将以最快的成长率成长。
  • 2023年销售份额为46.98%，临床检测占市场主导地位。随着医疗保健技术的快速发展，血液气体分析仪 (BGA) 已成为临床实验室的重要组成部分，可即时了解患者​​的呼吸和代谢状态。
  • 2023年北美占血气和电解质分析仪市场的42.22%。先进的医疗基础设施和优惠的报销计划是预计推动该地区市场成长的主要因素。
  • 印度和中国新兴市场存在大量未满足的需求，加上医疗基础设施的快速改善，预计将支持亚太地区在预测期内的良好成长率。对处理大量诊断测试的分散式照护现场诊断设施的需求不断增长，预计也将推动该地区的市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章血气与电解质分析仪市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 血气和电解质分析仪市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章血气和电解质分析仪市场：按产品估计和趋势分析

  • 全球血液气体和电解质分析仪市场：按产品分類的仪表板
  • 全球血液气体和电解质分析仪市场：按产品分类的波动分析
  • 全球血气及电解质分析仪市场：依产品、按收益
  • 装置
  • 消耗品

第五章血气和电解质分析仪市场：最终用途的估计和趋势分析

  • 全球血液气体和电解质分析仪市场：按最终用途分類的仪表板
  • 全球血液气体和电解质分析仪市场：最终用途的变化分析
  • 全球血气及电解质分析仪市场：依最终用途、按收益
  • 临床实验室
  • 照护现场
  • 诊断中心
  • 其他的

第六章血气和电解质分析仪市场：产品和最终用途的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • Abbott
    • Meizhou Cornley High-Tech Co., Ltd.
    • Radiometer Medical ApS
    • EDAN Instruments, Inc.
    • Erba Mannheim
    • F. Hoffmann-La Roche Ltd
    • Fortress Diagnostics
    • Werfen
    • LifeHealth
    • Medica Corporation
    • OPTI Medical Systems, Inc.,
    • Sensa Core
    • Siemens Healthineers AG
Product Code: 978-1-68038-420-8

Blood Gas And Electrolyte Analyzer Market Growth & Trends:

The global blood gas and electrolyte analyzer market size is expected to reach USD 3.71 billion by 2030, registering a CAGR of 4.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

Blood Gas And Electrolyte Analyzer Market Report Highlights:

  • Consumables dominated the market with a revenue share of 66.28% in 2023 and is anticipated to grow at the fastest growth rate over the forecast period, driven by their increasing demand.
  • Clinical laboratory dominated the market with a revenue market share of 46.98% in 2023. In the rapidly advancing landscape of healthcare technology, Blood Gas Analyzers (BGAs) have become indispensable for clinical laboratories, offering real-time insights into a patient's respiratory and metabolic status.
  • North America accounted for 42.22% of the blood gas and electrolyte analyzers market in 2023. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
  • Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product and end-use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Gas and Electrolyte Analyzer Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of chronic diseases
      • 3.2.1.2. Rising geriatric population
      • 3.2.1.3. Increasing regulatory support and funding
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced analyzers
      • 3.2.2.2. Shortage of skilled professionals
  • 3.3. Blood Gas and Electrolyte Analyzer Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Blood Gas and Electrolyte Analyzer Market: Product Estimates & Trend Analysis

  • 4.1. Global Blood Gas and Electrolyte Analyzer Market: Product Dashboard
  • 4.2. Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
  • 4.3. Global Blood Gas and Electrolyte Analyzer Market by Product, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Instruments, by Type
    • 4.4.3. Bench Top
      • 4.4.3.1. Benchtop instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.4. Portable
      • 4.4.4.1. Portable instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.5. Instruments, by Brand
    • 4.4.6. I-STAT
      • 4.4.6.1. I-STAT market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.7. epoc
      • 4.4.7.1. epoc market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.8. GEM Premier (3500& 5000)
      • 4.4.8.1. GEM Premier (3500& 5000) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.9. ABL Flex (90 and 800)
      • 4.4.9.1. ABL Flex (90 and 800) market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.10. Cobas
      • 4.4.10.1. Cobas market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.11. Portable RAPID Series
      • 4.4.11.1. RAPID series market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.12. Others
      • 4.4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Blood Gas and Electrolyte Analyzer Market: End Use Estimates & Trend Analysis

  • 5.1. Global Blood Gas and Electrolyte Analyzer Market: End Use Dashboard
  • 5.2. Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
  • 5.3. Global Blood Gas and Electrolyte Analyzer Market by End Use, Revenue
  • 5.4. Clinical Laboratory
    • 5.4.1. Clinical laboratory market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Point-of-care
    • 5.5.1. Point-of-care market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Blood Gas and Electrolyte Analyzer Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.6. Singapore
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.7. Malaysia
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.8. Indonesia
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.9. Thailand
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.10. Vietnam
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.5.11. Philippines
      • 6.5.11.1. Key country dynamics
      • 6.5.11.2. Regulatory framework/ reimbursement structure
      • 6.5.11.3. Competitive scenario
      • 6.5.11.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Abbott
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Meizhou Cornley High-Tech Co., Ltd.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Radiometer Medical ApS
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. EDAN Instruments, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Erba Mannheim
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. F. Hoffmann-La Roche Ltd
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Fortress Diagnostics
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Werfen
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. LifeHealth
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Medica Corporation
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. OPTI Medical Systems, Inc.,
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Sensa Core
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Siemens Healthineers AG
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Blood Gas and Electrolyte Analyzer, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 8 North America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 10 U.S. Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 11 Canada Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 12 Canada Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 13 Europe Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 14 Europe Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 15 Europe Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Germany Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 17 Germany Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 18 UK Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 19 UK Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 20 France Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 21 France Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Italy Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 23 Italy Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Spain Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 25 Spain Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 26 Denmark Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Sweden Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 29 Sweden Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Norway Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 31 Norway Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 35 China Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 36 China Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Japan Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 38 Japan Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 39 India Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 40 India Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 41 South Korea Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 42 South Korea Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Australia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 44 Australia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Singapore Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 46 Singapore Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Malaysia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 48 Malaysia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Indonesia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 50 Indonesia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Thailand Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 52 Thailand Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Vietnam Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 54 Vietnam Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Philippines Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 56 Philippines Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 57 Latin America Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 58 Latin America Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 59 Latin America Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Brazil Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 61 Brazil Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Mexico Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 63 Mexico Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Argentina Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 65 Argentina Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Country, 2018 - 2030 (USD Million)
  • Table 67 Middle East & Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 68 Middle East & Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 69 South Africa Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 70 South Africa Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 73 UAE Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 74 UAE Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)
  • Table 75 Kuwait Blood Gas and Electrolyte Analyzer, by Product, 2018 - 2030 (USD Million)
  • Table 76 Kuwait Blood Gas and Electrolyte Analyzer, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Blood Gas and Electrolyte Analyzer Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Blood Gas and Electrolyte Analyzer Market: Product Movement Analysis
  • Fig. 16 Global Blood Gas and Electrolyte Analyzer Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Blood Gas and Electrolyte Analyzer Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global Blood Gas and Electrolyte Analyzer Market: End Use Movement Analysis
  • Fig. 19 Global Blood Gas and Electrolyte Analyzer Market, for Clinical Laboratory, 2018 - 2030 (USD Million)
  • Fig. 20 Global Blood Gas and Electrolyte Analyzer Market, for Point-of-care, 2018 - 2030 (USD Million)
  • Fig. 21 Global Blood Gas and Electrolyte Analyzer Market, for Diagnostic Centers, 2018 - 2030 (USD Million)
  • Fig. 22 Global Blood Gas and Electrolyte Analyzer Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Marketplace: Key Takeaways
  • Fig. 24 Regional Outlook, 2023 & 2030
  • Fig. 25 Global Blood Gas and Electrolyte Analyzer Market: Region Movement Analysis
  • Fig. 26 North America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 32 France Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 44 Singapore Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 45 Malaysia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 46 Indonesia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 48 Vietnam Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 49 Philippines Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Blood Gas and Electrolyte Analyzer Market, 2018 - 2030 (USD Million)